<DOC>
	<DOCNO>NCT01603719</DOCNO>
	<brief_summary>The purpose clinical trial evaluate effect new infant starter formula add prebiotics ( GOS ) fat blend rich beta-palmitate .</brief_summary>
	<brief_title>Efficacy Safety Infant Formula With Milkfat Prebiotics</brief_title>
	<detailed_description>An experimental infant formula add prebiotics ( GOS ) high content palmitic acid esterify beta-position test double-blinded randomized control trial . The addition prebiotics infant formula favor growth beneficial bifidogenic intestinal flora positive effect immunity , promote soft stool formation short chain fatty acid content stool . Higher proportion beta-palmitic acid esterify 2nd position triglyceride reduce formation fatty acid-calcium soap stool promote calcium fat absorption gut , therfor reduce symptom constipation colic .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<criteria>healthy term neonates gestational age 37 42 week birth weight 10th 90th percentile ( Voigt reference ) infants exclusively formulafed enrollment infant high risk atopic disease due family history congenital disorder syndrome need special diet / impairment growth antibiotic medication prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>10 Days</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>infant formula</keyword>
	<keyword>prebiotics</keyword>
	<keyword>beta-palmitate</keyword>
	<keyword>stool flora</keyword>
	<keyword>bifidogenic</keyword>
</DOC>